Obstetrical and neonatal outcome after controlled ovarian stimulation for IVF using the GnRH antagonist ganirelix.

Autor: Boerrigter, Peter J, de Bie, Joris J, Mannaerts, Bernadette M J L, van Leeuwen, Bert P, Passier-Timmermans, Dorrie P J
Zdroj: Human Reproduction; August 2002, Vol. 17 Issue: 8 p2027-2034, 8p
Abstrakt: To establish long-term safety, follow-up data on pregnancy, birth and neonatal outcome were collected during clinical development trials with ganirelix (Orgalutran) in women undergoing controlled ovarian stimulation for conventional IVF or ICSI.
Databáze: Supplemental Index